Project Details
Description
An Open Label, Single Arm, Multi-Center Pharmacokinetic Study of Intravenous Erwinaze (asparaginase Erwinia chrysanthemi) Following Allergy to Native E. Coli Asparaginase (Elspar
Status | Finished |
---|---|
Effective start/end date | 11/5/12 → 12/31/14 |
Funding
- EUSA PHARMA, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.